2-Oleoylglycerol

2-Oleoylglycerol
Names
IUPAC name
2-O-[(9Z)-Octadec-9-enoyl]glycerol
Systematic IUPAC name
1,3-Dihydroxypropan-2-yl (9Z)-octadec-9-enoate
Other names
2-Monoolein
Identifiers
CAS Number
  • 3443-84-3 checkY
3D model (JSmol)
  • Interactive image
ChemSpider
  • 4478086 checkY
IUPHAR/BPS
  • 5112
PubChem CID
  • 5319879
UNII
  • 9A2389K694 checkY
CompTox Dashboard (EPA)
  • DTXSID8058661 Edit this at Wikidata
InChI
  • InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-20(18-22)19-23/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9- checkY
    Key: UPWGQKDVAURUGE-KTKRTIGZSA-N checkY
  • CCCCCCCCC=CCCCCCCCC(=O)OC(CO)CO
Properties
Chemical formula
C21H40O4
Molar mass 356.547 g·mol−1
Density 0.958 g/cm3
Hazards
Flash point > 113.0 °C (235.4 °F; 386.1 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references
Chemical compound

2-Oleoylglycerol (2OG) is a monoacylglycerol that is found in biologic tissues. Its synthesis is derived from diacylglycerol precursors. It is metabolized to oleic acid and glycerol primarily by the enzyme monoacylglycerol lipase (MAGL).[1] In 2011, 2OG was found to be an endogenous ligand to GPR119.[2] 2OG has been shown to increase glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) levels following administration to the small intestine.[2]

See also

References

  1. ^ Dinh, T. P.; Carpenter, D.; Leslie, F. M.; Freund, T. F.; Katona, I.; Sensi, S. L.; Kathuria, S.; Piomelli, D. (2002). "Brain monoglyceride lipase participating in endocannabinoid inactivation". Proceedings of the National Academy of Sciences. 99 (16): 10819–10824. Bibcode:2002PNAS...9910819D. doi:10.1073/pnas.152334899. PMC 125056. PMID 12136125.
  2. ^ a b Hansen, K. B.; Rosenkilde, M. M.; Knop, F. K.; Wellner, N.; Diep, T. A.; Rehfeld, J. F.; Andersen, U. B.; Holst, J. J.; Hansen, H. S. (2011). "2-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans". Journal of Clinical Endocrinology & Metabolism. 96 (9): E1409–E1417. doi:10.1210/jc.2011-0647. PMID 21778222.


  • v
  • t
  • e
Amino acid-derived
Major excitatory /
inhibitory systems
Glutamate system
GABA system
Glycine system
GHB system
Biogenic amines
Monoamines
Trace amines
Others
Neuropeptides
  • See here instead.
Lipid-derived
Endocannabinoids
Neurosteroids
  • See here instead.
Nucleobase-derived
Nucleosides
Adenosine system
Vitamin-derived
Miscellaneous
Cholinergic system
Gasotransmitters
Candidates
  • v
  • t
  • e
Receptor
(ligands)
CB1Tooltip Cannabinoid receptor type 1
Agonists
(abridged,
full list)
Inverse agonists
Antagonists
CB2Tooltip Cannabinoid receptor type 2
Agonists
Antagonists
NAGly
(GPR18)
Agonists
Antagonists
GPR55
Agonists
Antagonists
GPR119
Agonists
Transporter
(modulators)
eCBTsTooltip Endocannabinoid transporter
Enzyme
(modulators)
FAAHTooltip Fatty acid amide hydrolase
  • Activators: PDP-EA
MAGL
ABHD6
  • Inhibitors: JZP-169
  • JZP-430
  • KT182
  • KT185
  • KT195
  • KT203
  • LEI-106
  • ML294
  • ML295
  • ML296
  • UCM710
  • WWL-70
ABHD12
Others
  • Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)
  • ARN-272 (FAAH-like anandamide transporter inhibitor)
See also
Receptor/signaling modulators
Cannabinoids (cannabinoids by structure)